Lack of Evidence for PKM2 Protein Kinase Activity

Molecular Cell

Volumn 59, Issue 5, 2015, Pages 850-857

  Hosios, Aaron M ^a   Fiske, Brian P ^a   Gui, Dan Y ^a   Vander Heiden, Matthew G ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; PHOSPHATE; PHOSPHORUS 32; PYRUVATE KINASE; PYRUVATE KINASE M2; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; CARRIER PROTEIN; MEMBRANE PROTEIN; PHOSPHOENOLPYRUVATE; PROTEIN KINASE; RECOMBINANT PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ARTICLE; CANCER CELL; CELL LYSATE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; ANIMAL; CELL CULTURE; DEFICIENCY; ENZYME SPECIFICITY; GENE DELETION; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; GENE DELETION; GLYCOLYSIS; HUMANS; MEMBRANE PROTEINS; MICE; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; PROTEIN KINASES; PYRUVATE KINASE; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; THYROID HORMONES;

EID: 84940900111     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.07.013     Document Type: Article

References (30)

1. Anastasiou D., Yu Y., Israelsen W.J., Jiang J.K., Boxer M.B., Hong B.S., Tempel W., Dimov S., Shen M., Jha A., et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 2012, 8:839-847.
2. Beck M., Schmidt A., Malmstroem J., Claassen M., Ori A., Szymborska A., Herzog F., Rinner O., Ellenberg J., Aebersold R. The quantitative proteome of a human cell line. Mol. Syst. Biol. 2011, 7:549.
3. Carreras J., Climent F., Bartrons R., Pons G. Effect of vanadate on the formation and stability of the phosphoenzyme forms of 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase and of phosphoglucomutase. Biochim. Biophys. Acta 1982, 705:238-242.
4. Chaneton B., Hillmann P., Zheng L., Martin A.C., Maddocks O.D., Chokkathukalam A., Coyle J.E., Jankevics A., Holding F.P., Vousden K.H., et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 2012, 491:458-462.
5. Christofk H.R., Vander Heiden M.G., Wu N., Asara J.M., Cantley L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452:181-186.
6. Cortés-Cros M., Hemmerlin C., Ferretti S., Zhang J., Gounarides J.S., Yin H., Muller A., Haberkorn A., Chene P., Sellers W.R., Hofmann F. M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc. Natl. Acad. Sci. USA 2013, 110:489-494.
7. Deutscher J., Francke C., Postma P.W. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 2006, 70:939-1031.
8. Dombrauckas J.D., Santarsiero B.D., Mesecar A.D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005, 44:9417-9429.
9. Gao X., Wang H., Yang J.J., Liu X., Liu Z.R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 2012, 45:598-609.
10. Hitosugi T., Kang S., Vander Heiden M.G., Chung T.W., Elf S., Lythgoe K., Dong S., Lonial S., Wang X., Chen G.Z., et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2009, 2:ra73.
11. Israelsen W.J., Dayton T.L., Davidson S.M., Fiske B.P., Hosios A.M., Bellinger G., Li J., Yu Y., Sasaki M., Horner J.W., et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 2013, 155:397-409.
12. Jiang Y., Li X., Yang W., Hawke D.H., Zheng Y., Xia Y., Aldape K., Wei C., Guo F., Chen Y., Lu Z. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol. Cell 2014, 53:75-87.
13. Keller K.E., Tan I.S., Lee Y.S. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 2012, 338:1069-1072.
14. Keller K.E., Doctor Z.M., Dwyer Z.W., Lee Y.S. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol. Cell 2014, 53:700-709.
15. Kung C., Hixon J., Choe S., Marks K., Gross S., Murphy E., DeLaBarre B., Cianchetta G., Sethumadhavan S., Wang X., et al. Small molecule activation of PKM2 in cancer cells induces serine auxotrophy. Chem. Biol. 2012, 19:1187-1198.
16. Lunt S.Y., Muralidhar V., Hosios A.M., Israelsen W.J., Gui D.Y., Newhouse L., Ogrodzinski M., Hecht V., Xu K., Acevedo P.N., et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol. Cell 2015, 57:95-107.
17. Marcussen M., Larsen P.J. Cell cycle-dependent regulation of cellular ATP concentration, and depolymerization of the interphase microtubular network induced by elevated cellular ATP concentration in whole fibroblasts. Cell Motil. Cytoskeleton 1996, 35:94-99.
18. Mattoo R.L., Waygood E.B. An enzymatic method for [32P]phosphoenolpyruvate synthesis. Anal. Biochem. 1983, 128:245-249.
19. Mazurek S., Grimm H., Wilker S., Leib S., Eigenbrodt E. Metabolic characteristics of different malignant cancer cell lines. Anticancer Res. 1998, 18(5A):3275-3282.
20. McKnight S.L. Please keep me 2uned to PKM2. Mol. Cell 2014, 53:683-684.
21. Moellering R.E., Cravatt B.F. Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 2013, 341:549-553.
22. Morgan H.P., O'Reilly F.J., Wear M.A., O'Neill J.R., Fothergill-Gilmore L.A., Hupp T., Walkinshaw M.D. M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc. Natl. Acad. Sci. USA 2013, 110:5881-5886.
23. Plowman K.M., Krall A.R. A kinetic study of nucleotide interactions with pyruvate kinase. Biochemistry 1965, 4:2809-2814.
24. Schieven G., Martin G.S. Nonenzymatic phosphorylation of tyrosine and serine by ATP is catalyzed by manganese but not magnesium. J. Biol. Chem. 1988, 263:15590-15593.
25. Shechter D., Dormann H.L., Allis C.D., Hake S.B. Extraction, purification and analysis of histones. Nat. Protoc. 2007, 2:1445-1457.
26. Vander Heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., Christofk H.R., Wagner G., Rabinowitz J.D., Asara J.M., Cantley L.C. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
27. Wang X., Sato R., Brown M.S., Hua X., Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994, 77:53-62.
28. Wang Y.H., Israelsen W.J., Lee D., Yu V.W., Jeanson N.T., Clish C.B., Cantley L.C., Vander Heiden M.G., Scadden D.T. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell 2014, 158:1309-1323.
29. Yang W., Xia Y., Hawke D., Li X., Liang J., Xing D., Aldape K., Hunter T., Alfred Yung W.K., Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012, 150:685-696.
30. Yang W., Zheng Y., Xia Y., Ji H., Chen X., Guo F., Lyssiotis C.A., Aldape K., Cantley L.C., Lu Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 2012, 14:1295-1304.